carboplatin,etoposide,atezolizumab,tiragolumab
roche
['skyscraper-02', 'lung', 'lcsm,(-blcsm)', 'atezo', 'tiragolumab', 'sclc']
#asco22 skyscraper-02: atezo + carbo + etoposide w/ or w/out tiragolumab in pts w/ es-sclc results? negative again (pfs) for anti-tigit in #lungcancer the expectations were different for anti-tigit ..thas it! #lcsm
Thoracic oncologist & researcher @IEOufficiale; @myESMO Press & Media Chair; #LungCancer Molecular target-believer #LCSM